mycophenolate mofetil embryopathy
ORPHA: 268249
Overview
Mycophenolate mofetil (MMF) embryopathy is a malformative syndrome due to the teratogenic effect of MMF, an effective immunosuppressive agent widely used for the prevention of organ rejection after organ transplantation
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with mycophenolate mofetil embryopathy, sourced from HPO and Orphanet clinical annotations.
Ectopic kidneyOrofacial cleftHydrocephalusHypertelorismMicrognathiaHearing impairmentAtresia of the external auditory canalChorioretinal colobomaMicrophthalmiaVisual lossIris colobomaEyelid colobomaCongenital diaphragmatic herniaMild intellectual disabilityAgenesis of corpus callosumVentricular septal defectCoarctation of aortaHydrops fetalisHypoplastic toenailsFoot polydactylyTessier cleftTracheoesophageal fistulaTracheomalaciaShort palmBifid thoracic vertebraeMicrotiaAnotiaBifid nose
Classification & Codes
Orphanet Code
ORPHA:268249mycophenolate mofetil embryopathy
| Orphanet | ORPHA:268249 |
| Treatments | 0 drug(s) |
| Symptoms on record | 28 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO